These phospholipids aren't just a delivery vehicle
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
A highly absorbable, hydrolyzed formula guarantees these crucial building blocks are delivered successfully, giving your body the raw materials it needs for repair and regeneration
And resM - our clinically validated postbiotic formula with chromium, white mulberry, fenugreek, and vitamins D3 and B12 - is designed to complement GLP-1 therapy for patients who want digestive and metabolic support without adding another prescription.* Related Resources Tirzepatide vs Ozempic | Byetta vs Ozempic | Bydureon vs Ozempic | Wegovy vs Mounjaro References Wharton S, et al
Dhanapalaratnam R, Issar T, Lee ATK, Poynten AM, Milner KL, Kwai NCG, et al
doi: 10.1155/2020/9210572 338 NegroRHegedsLAttanasioRPapiniE